Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
synthetic cannabinoid
|
| gptkbp:actsOn |
CB1 receptor agonist
CB2 receptor agonist |
| gptkbp:CASNumber |
1801338-24-9
|
| gptkbp:chemicalFormula |
C18H26FN3O2
|
| gptkbp:effect |
psychoactive
cannabinoid-like effects |
| gptkbp:firstReported |
2013
|
| gptkbp:hasSMILES |
O=C(NC1C2CC3CC(C2)CC1C3)c4nn(CCCCC(F))c5ccccc45
|
| https://www.w3.org/2000/01/rdf-schema#label |
5F-AB-PINACA
|
| gptkbp:IUPACName |
N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide
|
| gptkbp:legal_status_in_UK |
Class B drug
|
| gptkbp:legalStatus |
Schedule I controlled substance
|
| gptkbp:molecularWeight |
335.42 g/mol
|
| gptkbp:PubChem_CID |
119025759
|
| gptkbp:relatedTo |
gptkb:5F-ADB
gptkb:AB-PINACA |
| gptkbp:routeOfAdministration |
oral
inhalation |
| gptkbp:UNII |
6Q1K1Q1K1E
|
| gptkbp:usedFor |
recreational drug
|
| gptkbp:bfsParent |
gptkb:MAU-209
|
| gptkbp:bfsLayer |
7
|